Global Health
1,200.80
-11.60(-0.96%)
Market Cap₹- Cr
PE Ratio-
Company Performance:
1D-0.96%
1M-3.88%
6M+0.33%
1Y+3.30%
5Y+189.14%
View Company Insightsright
More news about Global Health
15Aug 25
Medanta Reports Robust Q1 FY2026 Performance with 19% Revenue Growth and 50% PAT Surge
Global Health Limited (Medanta) reported robust Q1 FY2026 results. Total income increased 19% YoY to INR 10,513.00 million. EBITDA grew 23% to INR 2,553.00 million with a 24.30% margin. PAT surged 50% to INR 1,590.00 million. Operational metrics showed growth with inpatient volumes up 14%, outpatient volumes up 13%, and overall occupancy at 63%. International patient revenue increased 34% YoY. The company expanded with a new hospital in Ranchi and plans to add 2,000 beds over 3-4 years. Mature hospitals saw 11% income growth, while developing hospitals demonstrated 36% growth. Management highlighted the onboarding of over 150 doctors and attributed success to their integrated care model.
07Aug 25
Global Health Reports Strong Q1 FY2026 Results: Revenue Up 19%, EBITDA Grows 23%
Global Health Limited, operating as Medanta, reported robust Q1 FY2026 results. Consolidated total income reached ₹10,513.00 million, up 19.10% year-on-year. EBITDA grew 22.60% to ₹2,553.00 million, with margin improving to 24.30%. PAT surged 49.60% to ₹1,590.00 million. Operational metrics showed positive trends with increased occupied bed days, ARPOB, and patient volumes. Mature hospitals saw 10.70% revenue growth, while developing hospitals' revenue surged 35.90%. The company continues expansion with a new hospital in Ranchi and ongoing construction in Noida.
07Aug 25
Global Health Reports Robust Q1 FY2026 Results: Revenue Up 19.6%, Net Profit Surges 50%
Global Health Limited, operator of Medanta hospitals, reported robust Q1 FY2026 results. Revenue from operations grew 19.6% to ₹10,308.37 crore, while net profit jumped 49.6% to ₹1,589.82 crore. EBITDA increased to ₹2,270.00 crore with an improved margin of 22.02%. The company received an offer for land in Guwahati to establish a super specialty hospital. Board recommended re-appointments of key personnel, including Dr. Naresh Trehan as Chairman and Managing Director.
07Aug 25
Global Health Reports Strong Q1 FY2026 Results, Announces Key Board Reappointments
Global Health Limited, operator of Medanta hospitals, reported robust Q1 FY2026 results with consolidated revenue reaching ₹10,308.37 crore and profit after tax of ₹1,589.82 crore. The Board recommended reappointments of Dr. Naresh Trehan as Chairman and Managing Director, and Mr. Vikram Singh Mehta and Mr. Hari Shanker Bhartia as Independent Directors. The company scheduled its 21st AGM for September 19, 2025, and set a record date for a final dividend of ₹0.50 per share. Global Health also received a land offer in Guwahati for a potential super specialty hospital and approved an employee stock option plan.
24Jul 25
Medanta Secures 3.5-Acre Land Lease for Hospital Project in Guwahati
Global Health Limited (Medanta) has received approval from the Assam Cabinet for a 3.5-acre land allotment in Guwahati on a 60-year lease, extendable by 30 years. The lease includes an upfront charge of Rs. 56.00 crore and monthly estate charges. The land will house two hospitals and a hotel, with a common Floor Area Ratio approved for the entire parcel. This development marks a significant step in Medanta's expansion into Northeast India, potentially enhancing healthcare infrastructure in the region.
18May 25
Global Health Ltd Unveils Rs 4,000 Crore Expansion Plan Amid Q4 Profit Dip
Global Health Ltd, operator of Medanta hospitals, revealed a Rs 4,000 crore expansion plan to increase bed capacity to 6,000, with new centers in Noida, Guwahati, and Mumbai. Q4 results show 15.17% revenue growth to Rs 931.30 crore, but a 20.35% decline in net profit to Rs 101.40 crore. EBITDA margin contracted to 20.72% from 25.58%. Annual revenue increased by 15.53% to Rs 2,280 crore, with net profit growing 37.12% to Rs 360.90 crore.
15May 25
Global Health Reports Strong Q4 FY2023 Results with Revenue and EBITDA Growth
Global Health announced Q4 FY2023 results with revenue up 15.1% to ₹9.31 billion and EBITDA rising 25.7% to ₹2.25 billion. EBITDA margin improved to 24.13%. However, net profit decreased to ₹1.01 billion from ₹1.27 billion year-over-year, partly due to an exceptional item of ₹499 million. The results showcase robust operational performance despite challenges.
28Apr 25
Medanta Expands to Northeast: Plans ₹510 Crore Super Specialty Hospital in Guwahati
Global Health Ltd, parent of Medanta hospitals, plans to establish a 400+ bed super specialty hospital in Guwahati, Assam. The company will invest ₹510 crore, including ₹30 crore for a 3-acre land parcel. The hospital, to be developed over 3-4 years, will offer 20+ super specialties and serve 50 million people across Assam and neighboring states. This expansion marks Medanta's entry into Northeast India, adding to its existing 3,042-bed capacity across other locations.
07Apr 25
Global Health Eyes Expansion: Receives Land Offer for Super Speciality Hospital in Guwahati
Global Health Limited, operator of Medanta hospitals, has received an offer from Assam Electricity Grid Corporation Ltd (AEGCL) to acquire a 3-acre land parcel in Guwahati. The company is considering establishing a super speciality hospital in the region, potentially improving healthcare access in Northeast India. Management is currently evaluating the offer and will update stakeholders on material developments.
20Feb 25
NCLT Greenlights Merger of Medanta Holdings with Global Health
The National Company Law Tribunal (NCLT) has approved the merger between Medanta Holdings Private Limited (MHPL) and Global Health Limited (GHL), the parent company of Medanta hospitals. The amalgamation involves MHPL, a wholly-owned subsidiary, merging into GHL. The merger will be effective once the certified NCLT order is filed with the respective Registrar of Companies. This corporate action is expected to streamline operations and potentially enhance efficiency in the healthcare sector.
Global Health
1,200.80
-11.60
(-0.96%)
1 Year Returns:+3.30%
Industry Peers
Yatharth Hospital
683.70
(-0.64%)
Unihealth Hospitals
293.50
(-5.00%)
Nephro Care
128.70
(+0.08%)
Narayana Hrudayalaya
1,937.60
(-0.90%)
Apollo Hospitals
7,201.00
(+0.24%)
Maitreya Medicare
253.65
(+2.48%)
Global Health
1,200.80
(-0.96%)
GPT Healthcare
141.00
(+0.68%)
Shalby
200.64
(-1.59%)